Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham P Taylor

Showing results (181-190 of 228) with videos related to

Pageof 23
Sort By:
AIDS (London, England)|November 22, 2012
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant womenAngela P H Colbers, David A Hawkins, Andrea Gingelmaier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2004
The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant womenGraham P Taylor, Monique Bodéus, Françoise Courtois, et al.
European Journal of Immunology|December 10, 2025
IL-10- and IL-13-Biased T Cell Responses to SARS-CoV-2 Vaccination in DiabetesEmma M Jones, Caren Sourij, Martin Stradner, et al.
Haematologica|April 21, 2019
Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumabLucy B M Cook, Maria Antonietta Demontis, Sophie Sagawe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1Alison M Vine, Adrian G Heaps, Lambrini Kaftantzi, et al.
European Journal of Immunology|March 3, 2007
Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancyPascale Kropf, David Baud, Sara E Marshall, et al.
The Journal of Infectious Diseases|February 3, 2021
Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody ResponsesBenjamin H L Harris, Mohamed Zuhair, Matteo Di Giovannantonio, et al.
HIV Medicine|January 22, 2015
British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review)Annemiek de Ruiter, Graham P Taylor, Polly Clayden, et al.
AIDS (London, England)|June 26, 2007
Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failuresAndrew A Benzie, Loveleen K Bansi, Caroline A Sabin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2015
Raltegravir in HIV-1-Infected Pregnant Women: Pharmacokinetics, Safety, and EfficacyMaren I Blonk, Angela P H Colbers, Carmen Hidalgo-Tenorio, et al.
Pageof 23

Showing results (181-190 of 228) with videos related to

Sort By:
Pageof 23
AIDS (London, England)|November 22, 2012
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant womenAngela P H Colbers, David A Hawkins, Andrea Gingelmaier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2004
The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant womenGraham P Taylor, Monique Bodéus, Françoise Courtois, et al.
European Journal of Immunology|December 10, 2025
IL-10- and IL-13-Biased T Cell Responses to SARS-CoV-2 Vaccination in DiabetesEmma M Jones, Caren Sourij, Martin Stradner, et al.
Haematologica|April 21, 2019
Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumabLucy B M Cook, Maria Antonietta Demontis, Sophie Sagawe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2004
The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1Alison M Vine, Adrian G Heaps, Lambrini Kaftantzi, et al.
European Journal of Immunology|March 3, 2007
Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancyPascale Kropf, David Baud, Sara E Marshall, et al.
The Journal of Infectious Diseases|February 3, 2021
Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody ResponsesBenjamin H L Harris, Mohamed Zuhair, Matteo Di Giovannantonio, et al.
HIV Medicine|January 22, 2015
British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review)Annemiek de Ruiter, Graham P Taylor, Polly Clayden, et al.
AIDS (London, England)|June 26, 2007
Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failuresAndrew A Benzie, Loveleen K Bansi, Caroline A Sabin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2015
Raltegravir in HIV-1-Infected Pregnant Women: Pharmacokinetics, Safety, and EfficacyMaren I Blonk, Angela P H Colbers, Carmen Hidalgo-Tenorio, et al.
Pageof 23